SFB — Sopharma Buildings ADSITS Share Price
Last trade - 00:00- BGN58.50m
- BGN65.69m
- BGN0.09m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 8.16 | ||
| Price to Tang. Book | 8.16 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 688.22 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -0.62% | ||
| Return on Equity | -1.27% | ||
| Operating Margin | -108.24% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | BGNm | 0.15 | 0.08 | 0.26 | 0.06 | 0.09 | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | -93.43 | +3487.3 | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Sopharma Buildings ADSITS is a Bulgaria-based real estate investment trust, licensed by the Bulgarian Financial Supervision Commission. It specializes in the securitization of real estate. The Company invests in the real estate sector by purchasing titles and other rights over land and real estate. Sopharma Buildings ADSITS acquires property rights on self-contained individual properties, land, multifunctional administrative, residential, industrial and commercial buildings in Sofia in order to renovate, lease, rent or sell them. As of December 31, 2011, the Company’s major shareholder was Sopharma AD with a stake of 40.87%.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- August 14th, 2007
- Public Since
- June 25th, 2008
- Sector
- Residential & Commercial REITs
- Industry
- Financials
- Exchange
- Bulgarian Stock Exchange
- Shares in Issue
- 3,899,940
- Address
- Ul. Lachezar Stanchev 5, sgrada A, SOFIA, 1756
- Web
- https://sopharma-buildings.com/
- Phone
- +359 28134229
- Contact
- Ivanka Panova
- Auditors
- Baker Tilly Klitou and Partners OOD
Upcoming Events for SFB
Similar to SFB
Advance Terrafund ADSITS
Bulgarian Stock Exchange
Aktiv Properties ADSITS
Bulgarian Stock Exchange
Alteron ADSITS Varna
Bulgarian Stock Exchange
BPD Industrial Real Estate Fund ADSITS
Bulgarian Stock Exchange
Arco Towers ADSITS
Bulgarian Stock Exchange
FAQ
As of Today at 23:21 UTC, shares in Sopharma Buildings ADSITS are trading at BGN15.00. This share price information is delayed by 15 minutes.
Shares in Sopharma Buildings ADSITS last closed at BGN15.00 and the price had moved by over the past 365 days. In terms of relative price strength the Sopharma Buildings ADSITS share price has underperformed the FTSE Global All Cap Index by -2.5% over the past year.
There is no consensus recommendation for this security.
Find out moreSopharma Buildings ADSITS does not currently pay a dividend.
Sopharma Buildings ADSITS does not currently pay a dividend.
Sopharma Buildings ADSITS does not currently pay a dividend.
To buy shares in Sopharma Buildings ADSITS you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of BGN15.00, shares in Sopharma Buildings ADSITS had a market capitalisation of BGN58.50m.
Here are the trading details for Sopharma Buildings ADSITS:
- Country of listing: Bulgaria
- Exchange: BLG
- Ticker Symbol: SFB
Based on an overall assessment of its quality, value and momentum Sopharma Buildings ADSITS is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Sopharma Buildings ADSITS. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +13.49%.
As of the last closing price of BGN15.00, shares in Sopharma Buildings ADSITS were trading -18.52% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Sopharma Buildings ADSITS PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at BGN15.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Sopharma Buildings ADSITS' management team is headed by:
- Emil Kostov - CEO
- Petya Petkova - CAO
- Irina Mincheva - DRC
- Stoycho Pangev - DRC